Patient satisfaction

The superior longevity and unique profile of Radiesse® dermal filler deliver excellent results to a wide variety of patients.

• RADIESSE dermal filler is preferred by more patients than other leading dermal fillers.²
• Clinical studies show that RADIESSE patients are happier with their result. And they are more likely to return for additional treatments compared to patients using other leading wrinkle fillers.¹

In two head-to-head clinical studies, RADIESSE dermal filler was shown to have significantly greater patient satisfaction compared to Hyaluronic acid products.¹ The graphs below show the results of patient questionnaires for both studies asking about their satisfaction level with the filler they received.

More patients return

Patients treated with RADIESSE dermal filler also said they were much more likely to return for additional treatments.

1. Based on a clinical study of 205 patients who were treated with a regimen of RADIESSE, Juvéderm and Perlane fillers. Patients were provided with a questionnaire and asked to rate the level of satisfaction at 4, 8, and 12 months post second injection. Patients were provided a yes/no questionnaire to address recommendations of RADIESSE dermal filler or other products at 4, 8, and 12 months. Moers-Carpi, M. M., Vogt, S., Santos, B. M., Planas, J., Vallve, S. R., and Howell, D. J. (2007). A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. American Society for Dermatologic Surgery, 33: S144-S151.
2. Based on a clinical study of 60 patients who were treated with a regimen of 2 injections 3 months apart with RADIESSE and Restylane fillers. Masked evaluaters measured effectiveness at 3, 6, and 9 months psot second injection. Moers-Carpi, M. M., and Tufet, J. O. (2007). Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: A 12-month, multicenter, prospective, randomized, controlled, split-face trial. American Society for Dermatologic Surgery, 34, 1-6.
3. Data on file. Based on a split-faced nasolabial fold trial of 60 patients who were treated with a regimen of 2 injections 3 months apart with RADIESSE and Restylane.